Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases. This ...
Using generative artificial intelligence (generative AI), scientists from Massachusetts Institute of Technology (MIT) and their collaborators elsewhere designed novel antibiotics capable of combating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results